Rethymic Implant
- RxCUI
- 2626469
- RxNorm name
- Rethymic Implant
- Display name
- Rethymic Implant
- Full name
- Rethymic Implant
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125685 | Rethymic | allogeneic processed thymus tissue-agdc | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RETHYMIC | ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC | Sumitomo Pharma America, Inc. | e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | 2025-10-31 | Warnings, Adverse reactions | 2626469 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | Rethymic Implant | SY | 8 | These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 2021 | 20251031 |
| e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant [Rethymic] | SBD | 8 | These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 2021 | 20251031 |
| e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | Rethymic 22,000 mm2 Implant | SY | 8 | These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 2021 | 20251031 |
| e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | Rethymic 220 SQCM Implant | SY | 8 | These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 2021 | 20251031 |
| e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | RETHYMIC Implant | PSN | 8 | These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 2021 | 20251031 |